304
Views
8
CrossRef citations to date
0
Altmetric
Review

Growth in CHARGE syndrome: optimizing care with a multidisciplinary approach

, &
Pages 607-620 | Published online: 01 Aug 2019

References

  • Janssen N, Bergman JEH, Swertz MA, et al. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012;33(8):1149–1160. doi:10.1002/humu.2208622461308
  • Pagon RA, Graham JM Jr, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99(2):223–227. doi:10.1016/s0022-3476(81)80454-46166737
  • Blake KD, Davenport SL, Hall BD, et al. CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila). 1998;37(3):159–173. doi:10.1177/0009922898037003029545604
  • Verloes A. Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet. 2005;133A(3):306–308. doi:10.1002/ajmg.a.3055915666308
  • Vissers LELM, van Ravenswaaij CMA, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004;36(9):955–957. doi:10.1038/ng140715300250
  • Jongmans MCJ, Admiraal RJ, van der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43(4):306–314. doi:10.1136/jmg.2005.03606116155193
  • Legendre M, Abadie V, Attie-Bitach T, et al. Phenotype and genotype analysis of a French cohort of 119 patients with CHARGE syndrome. Am J Med Genet C Semin Med Genet. 2017;175(4):417–430. doi:10.1002/ajmg.c.3159129178447
  • Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, et al. CHD7 mutations in patients initially diagnosed with Kallmann syndrome–the clinical overlap with CHARGE syndrome. Clin Genet. 2009;75(1):65–71. doi:10.1111/j.1399-0004.2008.01107.x19021638
  • Marcos S, Sarfati J, Leroy C, et al. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients. J Clin Endocrinol Metab. 2014;99(10):2138. doi:10.1210/jc.2014-211024606104
  • Bergman JEH, Janssen N, van der Sloot AM, et al. A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome. Hum Mutat. 2012;33(8):1251–1260. doi:10.1002/humu.2210622539353
  • Lalani SR, Safiullah AM, Fernbach SD, et al. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet. 2006;78(2):303–314. doi:10.1086/50027316400610
  • Jongmans MCJ, Hoefsloot LH, van der Donk KP, et al. Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability. Am J Med Genet A. 2008;146A(1):43–50. doi:10.1002/ajmg.a.3192118074359
  • Hale CL, Niederriter AN, Green GE, Martin DM. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria. Am J Med Genet A. 2016;170A(2):344–354. doi:10.1002/ajmg.a.3743526590800
  • Blake KD, Salem-Hartshorne N, Daoud MA, Gradstein J. Adolescent and adult issues in CHARGE syndrome. Clin Pediatr (Phila). 2005;44(2):151–159. doi:10.1177/00099228050440020715735833
  • Husu E, Hove HD, Farholt S, et al. Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome. Clin Genet. 2013;83(2):125–134. doi:10.1111/j.1399-0004.2012.01884.x22462537
  • Shoji Y, Ida S, Etani Y, et al. Endocrinological characteristics of 25 Japanese patients with CHARGE syndrome. Clin Pediat Endocrinol. 2014;23(2):45–51. doi:10.1297/cpe.23.45
  • Bergman JEH, Bocca G, Hoefsloot LH, Meiners LC, van Ravenswaaij-Arts CMA. Anosmia predicts hypogonadotropic hypogonadism in CHARGE syndrome. J Pediatr. 2011;158(3):474–479. doi:10.1016/j.jpeds.2010.08.03220884005
  • Pinto G, Abadie V, Mesnage R, et al. CHARGE Syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J Clin Endocrinol Metab. 2005;90(10):5621–5626. doi:10.1210/jc.2004-247416030162
  • Hartshorne TS, Stratton KK, Brown D, Madhavan-Brown S, Schmittel MC. Behavior in CHARGE syndrome. Am J Med Genet C Semin Med Genet. 2017;175(4):431–438. doi:10.1002/ajmg.c.3158829082623
  • Bergman JE, de Ronde W, Jongmans MC, et al. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome. J Clin Endocrinol Metab. 2012;97(5):858. doi:10.1210/jc.2011-2652
  • Aramaki M, Udaka T, Kosaki R, et al. Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr. 2006;148(3):410–414. doi:10.1016/j.jpeds.2005.10.04416615981
  • Aguiar-Oliveira MH, Davalos C, Campos VC, Oliveira Neto LA, Marinho CG, Oliveira CRP. Hypothalamic abnormalities: growth failure due to defects of the GHRH receptor. Growth Horm IGF Res. 2018;38:14–18. doi:10.1016/j.ghir.2017.12.01129277338
  • Asakura Y, Toyota Y, Muroya K, et al. Endocrine and radiological studies in patients with molecularly confirmed CHARGE syndrome. J Clin Endocrinol Metab. 2008;93(3):920–924. doi:10.1210/jc.2007-141918089695
  • Blake K, Kirk JM, Ur E. Growth in CHARGE association. Arch Dis Child. 1993;68(4):508–509. doi:10.1136/adc.68.4.5088503679
  • Dauber A, Hirschhorn JN, Picker J, Maher TA, Milunsky A. Delayed puberty due to a novel mutation in CHD7 causing CHARGE syndrome. Pediatrics. 2010;126(6):1594. doi:10.1542/peds.2010-0164
  • Dörr HG, Madeja J, Junghans C. Spontaneous postnatal growth is reduced in children with CHARGE syndrome. Acta Paediatr Int J Paediatr. 2015;104(7):e318. doi:10.1111/apa.12980
  • Harvey AS, Leaper PM, Bankier A. CHARGE association: clinical manifestations and developmental outcome. Am J Med Genet. 1991;39(1):48–55. doi:10.1002/ajmg.13203901121867265
  • Searle LC, Graham JM Jr, Prasad C, Blake KD. CHARGE syndrome from birth to adulthood: an individual reported on from 0 to 33 years. Am J Med Genet A. 2005;133A(3):344–349. doi:10.1002/ajmg.a.3056515637714
  • Legendre M, Gonzales M, Goudefroye G, et al. Antenatal spectrum of CHARGE syndrome in 40 fetuses with CHD7 mutations. J Med Genet. 2012;49(11):698–707. doi:10.1136/jmedgenet-2012-10092623024289
  • Khadilkar VV, Cameron FJ, Stanhope R. Growth failure and pituitary function in CHARGE and VATER associations. Arch Dis Child. 1999;80(2):167–170. doi:10.1136/adc.80.2.16710325734
  • Forward KE, Cummings EA, Blake KD. Risk factors for poor bone health in adolescents and adults with CHARGE syndrome. Am J Med Genet A. 2007;143A(8):839–845. doi:10.1002/ajmg.a.3167017366585
  • Dobbelsteyn C, Peacocke SD, Blake K, Crist W, Rashid M. Feeding difficulties in children with CHARGE syndrome: prevalence, risk factors, and prognosis. Dysphagia. 2008;23(2):127–135. doi:10.1007/s00455-007-9111-618027028
  • Blake KD, Hudson AS. Gastrointestinal and feeding difficulties in CHARGE syndrome: a review from head-to-toe. Am J Med Genet Part C Semin Med Genet. 2017;175(4):496–506. doi:10.1002/ajmg.c.3158629082627
  • Dobbelsteyn C, Marche DM, Blake K, Rashid M. Early oral sensory experiences and feeding development in children with CHARGE syndrome: a report of five cases. Dysphagia. 2005;20(2):89–100. doi:10.1007/s00455-004-0026-116172816
  • Hudson A, Macdonald M, Friedman JN, Blake K. CHARGE syndrome gastrointestinal involvement: from mouth to anus. Clin Genet. 2017;92(1):10–17. doi:10.1111/cge.1289228155231
  • Blake K, MacCuspie J, Hartshorne TS, Roy M, Davenport SLH, Corsten G. Postoperative airway events of individuals with CHARGE syndrome. Int J Pediatr Otorhinolaryngol. 2008;73(2):219–226. doi:10.1016/j.ijporl.2008.10.00519058860
  • Valla F, Berthiller J, Gaillard-Le-Roux B, et al. Faltering growth in the critically ill child: prevalence, risk factors, and impaired outcome. Eur J Pediatr. 2018;177(3):345–353. doi:10.1007/s00431-017-3062-129243190
  • Hulst J, Joosten K, Zimmermann L, et al. Malnutrition in critically ill children: from admission to 6 months after discharge. Clin Nutr. 2004;23(2):223–232. doi:10.1016/S0261-5614(03)00130-415030962
  • Corsten-Janssen N, Scambler PJ. Clinical and molecular effects of CHD7 in the heart. Am J Med Genet Part C Semin Med Genet. 2017;175(4):487–495. doi:10.1002/ajmg.c.3159029088513
  • Medoff-Cooper B, Ravishankar C. Nutrition and growth in congenital heart disease: a challenge in children. Curr Opin Cardiol. 2013;28(2):122–129. doi:10.1097/HCO.0b013e32835dd00523370229
  • Ravishankar C, Zak V, Williams IA, et al. Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the pediatric heart network infant single ventricle trial. J Pediatr. 2013;162(2):256.e2. doi:10.1016/j.jpeds.2012.07.048
  • Jain S, Kim HG, Lacbawan F, et al. Unique phenotype in a patient with CHARGE syndrome. Int J Pediatr Endocrinol. 2011;2011:11. doi:10.1186/1687-9856-2011-1121995344
  • Dörr HG, Boguszewski M, Dahlgren J, et al. Short children with charge syndrome: do they benefit from growth hormone therapy? Horm Res Paediatr. 2015;84(1):49–53. doi:10.1159/00038201726044035
  • Bergman JE, Janssen N, Hoefsloot LH, Jongmans MC, Hofstra RM, van Ravenswaaij-Arts CM. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet. 2011;48(5):334–342. doi:10.1136/jmg.2010.08710621378379
  • Balasubramanian R, Choi JH, Francescatto L, et al. Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency. Proc Natl Acad Sci USA. 2014;111(50):17953–17958. doi:10.1073/pnas.141743811125472840
  • Costa-Barbosa FA, Balasubramanian R, Keefe KW, et al. Prioritizing genetic testing in patients with kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab. 2013;98(5):E943; E953. doi:10.1210/jc.2012-4116
  • Xu C, Cassatella D, van der Sloot AM, et al. Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants. Genet Med. 2018;20(8):872–881. doi:10.1038/gim.2017.19729144511
  • Dunkel L, Quinton R. Transition in endocrinology: induction of puberty. Eur J Endocrinol. 2014;170(6):R239. doi:10.1530/EJE-13-0894
  • Zirilli L, Rochira V, Diazzi C, Caffagni G, Carani C. Human models of aromatase deficiency. J Steroid Biochem Mol Biol. 2008;109(3–5):212–218. doi:10.1016/j.jsbmb.2008.03.02618448329
  • Blake KD, Russell-Eggitt IM, Morgan DW, Ratcliffe JM, Wyse RK. Who’s in CHARGE? Multidisciplinary management of patients with CHARGE association. Arch Dis Child. 1990;65(2):217–223. doi:10.1136/adc.65.2.2172317068
  • Blake KD, Prasad C. CHARGE syndrome. Orphanet J Rare Dis. 2006;1:34. doi:10.1186/1750-1172-1-3416959034
  • White PH, Cooley WC. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics. 2018;142:5. doi:10.1542/peds.2018-2587
  • Van Lierde A, Menni F, Bedeschi MF, et al. Healthcare transition in patients with rare genetic disorders with and without developmental disability: neurofibromatosis 1 and Williams-Beuren syndrome. Am J Med Genet A. 2013;161A(7):1666–1674. doi:10.1002/ajmg.a.3598223696535
  • Hughes-McCormack LA, Rydzewska E, Henderson A, MacIntyre C, Rintoul J, Cooper S. Prevalence and general health status of people with intellectual disabilities in Scotland: a total population study. J Epidemiol Community Health. 2018;72(1):78–85. doi:10.1136/jech-2017-20974829070675
  • Krahn GL, Hammond L, Turner A. A cascade of disparities: health and health care access for people with intellectual disabilities. Ment Retard Dev Disabil Res Rev. 2006;12(1):70–82. doi:10.1002/mrdd.2009816435327
  • Franklin MS, Beyer LN, Brotkin SM, Maslow GR, Pollock MD, Docherty SL. Health care transition for adolescent and young adults with intellectual disability: views from the parents. J Pediatr Nurs. 2019;47:148–158. doi:10.1016/j.pedn.2019.05.00831152999
  • Gabriel P, McManus M, Rogers K, White P. Outcome evidence for structured pediatric to adult health care transition interventions: a systematic review. J Pediatr. 2017;188:269.e15. doi:10.1016/j.jpeds.2017.05.066
  • Schrander-Stumpel CTRM, Sinnema M, van Den Hout L, et al. Healthcare transition in persons with intellectual disabilities: general issues, the Maastricht model, and Prader-Willi syndrome. Am J Med Genet C Semin Med Genet. 2007;145C(3):241–247. doi:10.1002/ajmg.c.3013617639594
  • Peron A, Canevini MP, Ghelma F, Di Marco F, Vignoli A. Healthcare transition from childhood to adulthood in tuberous sclerosis complex. Am J Med Genet C Semin Med Genet. 2018;178(3):355–364. doi:10.1002/ajmg.c.3165330253036
  • Craig D, Fayter D, Stirk L, Crott R. Growth monitoring for short stature: update of a systematic review and economic model. Health Technol Assess. 2011;15(11):iii.
  • Victora CG, Adair L, Fall C, et al. Maternal and child undernutrition: consequences for adult health and human capital. Lancet. 2008;371(9609):340–357. doi:10.1016/S0140-6736(07)61692-418206223
  • Martorell R, Horta BL, Adair LS, et al. Weight gain in the first two years of life is an important predictor of schooling outcomes in pooled analyses from five birth cohorts from low- and middle-income countries. J Nutr. 2010;140(2):348–354. doi:10.3945/jn.109.11230020007336
  • Trider C, Arra-Robar A, van Ravenswaaij-Arts C, Blake K. Developing a CHARGE syndrome checklist: health supervision across the lifespan (from head to toe). Am J Med Genet Part A. 2017;173(3):684–691. doi:10.1002/ajmg.a.3808528160409
  • de Geus CM, Free RH, Verbist BM, et al. Guidelines in CHARGE syndrome and the missing link: cranial imaging. Am J Med Genet Part C Semin Med Genet. 2017;175(4):450–464. doi:10.1002/ajmg.c.3159329168326
  • Wincent J, Holmberg E, Stromland K, et al. CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome. Clin Genet. 2008;74(1):31–38. doi:10.1111/j.1399-0004.2008.01014.x18445044
  • Delahaye A, Sznajer Y, Lyonnet S, et al. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. Clin Genet. 2007;72(2):112–121. doi:10.1111/j.1399-0004.2007.00821.x17661815
  • Pauli S, Pieper L, Häberle J, et al. Proven germline mosaicism in a father of two children with CHARGE syndrome. Clin Genet. 2009;75(5):473–479.19475719